Pneumocystis carinii pneumonia prophylaxis in patients with rheumatic diseases undergoing immunosuppressive therapy: Prevalence and associated features

Journal of Clinical Rheumatology

Volumn 6, Issue 2, 2000, Pages 94-101

  Vernovsky, Inna ^a   Dellaripa, Paul F ^a,b,c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Non HIV PCP; PCP; Pneumocystis carinii; Rheumatic diseases

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; PNEUMOCYSTIS PNEUMONIA; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATIC DISEASE; SEROCONVERSION; WEGENER GRANULOMATOSIS;

EID: 0034050108     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200004000-00007     Document Type: Article

References (74)

1. Gajdushek DC. Pneumocystis carinii - etiologic agent of interstitial plasma cell pneumonia of premature and young children. Pediatrics 1957;19:543-65.
2. Dutz W. Pneumocystis carinii pneumonia. Pathol Annu 1970;5:309-41.
3. Vogel CL, Cohen MH, Powel RD, DeVita VT. Pneumocystis carinii pneumonia. Ann Intern Med 1968;68:97-108.
4. Le Clair RA. Descriptive epidemiology of interstitial pneumocystic pneumonia: an analysis of 107 cases from the United States, 1955-1967. Am Rev Respir Dis 1969;99:542-7.
5. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States. Ann Intern Med 1974;80: 83-93.
6. Rosen P, Armstrong D, Ramos C. Pneumocystis carinii pneumonia: a clinicopathologic study of twenty patients with neoplastic diseases. Am J Med 1972;53:428-36.
7. Hughes WT, Price RA, Kim HK, Coburn TP, Grigsby D, Schonland M et al. Pneumocystis carinii pneumonia in children with malignancies. J Pediatr 1973;82:404-15.
8. Hughes WT, Price RA, Sisko F, et al. Protein-calorie malnutrition: a host determinant for Pneumocystis carinii infection. Am J Dis Child 1974;128:44-52.
9. Centers for Disease Control. Acquired immunodeficiency syndrome (AIDS) update: United States. MMWR Morb Mortal Wkly Rep 1983; 32:309-11.
10. Detels R. Epidemiologic perspectives: the acquired immunodeficiency syndrome. Ann Intern Med 1983;99:208-20.
11. Centers for Disease Control: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Morb Mortal Wkly Rep 1995;44(RR-8):1-34.
12. Schneider MME, Hoepelman AIM, Eeftinck Schattenderk JKM, Nielsen TL, Van Der Gruat Y, Frissen JPHJ, et. al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1836-1841.
13. Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993;17 Suppl 2:S416-422.
14. Arend SM, Kroon PK, Van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch Intern Med 1995;155:2436-43.
15. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162:233-5.
16. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998;113(5):1215-24.
17. Huynch-Do U, Gantenbein H, Binswanger U. Pneumocystis carinii pneumonia during immunosuppressive therapy for antineutrophil cytoplasmic autoantibody-positive vasculitis. Arch Intern Med 1995;155:872-4.
18. Singer C, Armstrong D, Rosen PP, Schottenfeld D. Pneumocystis carinii pneumonia: a cluster of 11 cases. Ann Intern Med 1975;82:772.
19. Chave JP, David S, Wauters JP, Van Melle G, Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients AIDS 1991;5:927-32.
20. Jacobs JL, Libby DM, Winters RA, Gelmont DM, Fried EF. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med 1991;324;246-50.
21. Haron E, Bodey G, Luna MA. Has the incidence of Pneumocystis carinii pneumonia in cancer patients increased with AIDS epidemics? Lancet 1988:2;904-5.
22. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13.
23. Peters SG, Udaya P. Pneumocystis carinii Pneumonia: review of 53 cases. Am J Med 1987;82:73-8.
24. Dohn MN, Bauhman RP, Vigdorth EM, Frame DL. Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Arch Intern Med 1992;152: 2465-70.
25. Kovacs JA, Heimenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii Pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100:663-71.
26. Chechani V, Bridges A. Pneumocystis carinii pneumonia in patients with connective tissue disease. Chest 1992;101:375-8.
27. Godeau B, Coutant-Perronne V, Huong DLT, Guillevin L, Magadur G, DeBandt M, et al. Pneumocystis carinii Pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994;21:246-51.
28. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21:37-44.
29. Meyers JD, Pifer LL, Sale GE, Thomas ED. The value of Pneumocystis carinii antibody and antigen detection for the diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 1979;120: 1283-7.
30. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 1982;4:1119-32.
31. Hardy AM, Wajszczuk CP, Suffredini AF, Hakala TR, Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporin and steroids. J Infect Dis 1984;149:143-7.
32. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988;67:132-43.
33. Brooks RG, Hoffla JM, Jamieson SW, Stinson EB, Remington JS. Infectious complications in heart-lung transplant recipients. Am J Med 1985;79:412-22.
34. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987;106:209-16.
35. Olsen SO, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole. Transplantation 1993;56:359-62.
36. Gryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Am Rev Respir Dis 1988;137:1268-74.
37. Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimetoprim-sulfametoxazole prophylaxis for Pneumocystis carinii infec-tions in heart-lung and lung transplantation: how effective and for how long? Transplantation 1992;53:586-9.
38. Smith MB, Hanauer SB. Pneumocystis carinii pneumonia during cyclosporin therapy for ulcerative colitis. N Engl J Med 1992;327:497-8.
39. Bernstein CN, Kolodny M, Block E, Shanahan F. Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with steroids. Am J Gastroenterol 1993;88:574-7.
40. Cano B, Capote F, Pereira A, Calderon E, Castillo J. Pneumocystis carinii pneumonia patients without predisposing illnesses: acute episodes and follow-up of five cases. Chest 1993;104:376-81.
41. Porges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus are at risk for Pneumocystis carinii pneumonia. J Rheumatol 1992;9:1191-4.
42. Kadoya A, Okada J, Iikuni Y. Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186-8.
43. Flood DA, Chan CK, Pruzanski VV. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J Rheumatol 1991;18:1254-6.
44. Ward MW, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases. Arthritis Rheum 1999;4:780-9.
45. Boerbooms AM, Kerstens P, Loenhout J, Mulder J, Putte L. Infections during low dose methotrexate treatment in rheumatoid arthritis. Semin Arthritis Rheum 1995;6:411-21.
46. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine 1987;66:341-7.
47. Jarrousse B, Guillevin L, Bindi P, Hachulla E, Leclerc P, Nilson B, et. al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 1993;11:615-21.
48. Godeau B, Mainardi JL, Roudot-Thoraval F, Hachulla E, Guillevin L, Huong Du LT, et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 1995;54:991-4.
49. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995;151:795-9.
50. Graham BS, Tucker WS. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984;101:334-8.
51. Silverman ED, Myones BL, Miller JJ. Lymphocyte subpopulation alterations induced by intravenous megadose pulse methylprednisolone. J Rheumatol 1984;11:287-90.
52. Faure G, Bene MC, Bordigoni P. Peripheral T-cell subset modifications induced by steroid pulse in a case of Still's disease. Arthritis Rheum 1984;27:718-9.
53. Walzer PD, LaBine M, Redington TJ, Cushion MT. Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia. J Immunol 1984;133:2502-8.
54. Shellito J, Suzara VV, Blumefeld W, Beck JM, Steger HJ, Ermack TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686-93.
55. Von Behren LA, Pesanti EL. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis 1978;118: 1051-9.
56. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun 1992;60:1-7.
57. Slivka A, Wen PY, Shea WM, Loeffler JS. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 1993;94:216-9.
58. Sen RP, Walsh TE, Fisher WM, Brock N. Pulmonary complications of combination therapy with cyclophosphamide and prednisone. Chest 1991;99:143-6.
59. Wollner A, Mohle-Boetani J, Lambert RE, Perruguet JL, Raffin TA, McGuire JL. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax 1991;46:205-7.
60. Hoffman GS, Kerr GS, Laevitt RY, Hallahan CW, Lebovics RS, Travis WD, et. al Wegeners' granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
61. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis Carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med 1990;322:161-5.
62. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus infection. Ann Intern Med 1989;111:223-31.
63. Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H. Peripheral CD4+ T-lymphocyte counts in non-HIV Pneumocystis carinii. Am J Resp Crit Care Med 1999;159(3) Suppl Part 2. Abstract.
64. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty-two Wegener's granulomastosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995;38:608-13.
65. Hughes WT, Kuhn S, Chaudhary S, Feldmen S, Verzosa M, Aur RJA, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977;297:1419-26.
66. Chung JB, Albert DA. Cost effectiveness analysis of Pneumocystis Carinii Pneumonia (PCP) prophylaxis with trimethoprim-sulfamethoxazole in patients with systemic lupus erythematosus (SLE) or Wegener's granulomatosis (WG) on immunosuppressive therapy. Arthritis Rheum 1998;41: Abstract S75.
67. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. N Engl J Med 1987;316.1627-32.
68. Ioannidis JP, Capelleri JC, Skolnik PR, Lau J, Sacks HS. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii pneumonia prophylactic regimens. Arch Intern Med 1996;156:177-88.
69. Jorde UP, Horowitz HW, Wormser GP. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV infected individuals. AIDS 1993;7:355-9.
70. Bradburne PM, Bettensohn DB, Opal SM, McCool FD. Relapse of Pneumocystis carinii pneumonia in the upper lobes during aerosol pentamidine prophylaxis. Thorax 1989;44:591-3.
71. Bozette SA, Finklestein SA, Spector P, Frame P, Powderly WG, He W. A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection. New Engl J Med 1995;332:693-9.
72. Fischl MA, Dickinson GM. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:629.
73. Hughes WT, Leoung G, Kramer F, Bozette SA, Safrin S, Frame P, et al. Comparison of atovaquone (566C80) and trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Eng J Med 1193;328:1521-7.
74. Kay R, DuBois RE. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. South Med J 1990;83:403-4.